Asia-Pacific Fertility Services Market Overview:
The Asia-Pacific fertility services market size was valued at $4,529.06 million in 2020, and is expected to reach $20,492.95 million by 2030, registering a CAGR of 15.5% from 2021 to 2030.
Fertility services support the treatments used to cure infertility. These services often include techniques like artificial insemination, in vitro fertilization (IVF), surrogacy, and others. Infertility, in general, is defined as not being able to conceive after a year of unprotected coitus. It can occur in both males and females of child-bearing age. In men, infertility is caused by different factors which are generally analyzed by a semen analysis. Some of the factors which are highly likely to cause male infertility include trauma to the testes, varicoceles (a condition in which the testicle veins are large causing overheat. This affects the size of the sperms), use of certain medications, and medical conditions like diabetes, autoimmune disorders, and cystic fibrosis. On the other hand, in females, infertility is often caused due to disruptions of ovarian function with age. However, other causes might include polycystic ovarian syndrome (PCOS), diminished ovarian reserve, functional hypothalamic amenorrhea (FHA), and premature ovarian insufficiency (POI).
Rise in awareness regarding different infertility treatments, decline in fertility rate, technological advancements made in the field of assisted reproductive technologies (ART), and the growth in fertility clinics in the Asia-Pacific region are likely to boost the growth of the Asia-Pacific fertility services market during the forecast period. However, the high cost associated with these infertility treatments is one of the factors that can impede the market growth. Certain factors which can increase the risk of infertility include age, use of marijuana, excessive alcohol use, exposure to testosterone, exposure to radiation, and extreme weight gain or weight loss. About 1 in 6 couples have fertility problems when the woman is 35 and older. Aging is known to decrease fertility because older women have fewer eggs. In addition, aging also increases the chances of a miscarriage. The rise in awareness regarding surrogacy and egg/sperm donation has increased the growth of the market. Furthermore, the rise in the median age of first-time motherhood is also fuelling the market growth as women now tend to focus on their career first before they choose to become a mother for the first time. With a sedentary and fast-paced lifestyle, most women tend to suffer from different gynecological conditions which further reduce their chances of conceiving naturally and augment the growth of the Asia-Pacific fertility services market.
COVID-19 impact on the fertility services market
The COVID-19 outbreak that started from Wuhan city of China has now spread globally. Almost every nation is dealing with the outbreak. Most markets are experiencing a decline, owing to the outbreak. This also includes the fertility services market. The fertility services market is negatively impacted by the pandemic. In addition, most fertility clinics across the globe have stopped undertaking new cases of infertility treatment for the next few months, till the condition seems to be under control.
For instance, on March 17, 2020, the American Society for Reproductive Medicine (ASRM) issued certain recommendations that included not initiating new cycles of assisted ovulation, intrauterine inseminations (IUIs), in vitro fertilization (IVF), or “non-urgent” egg freezing. Some women have postponed their fertility consultations, whereas others have delayed their dates of embryo transfer until the pandemic situation ends and life comes back to normal.
In the ongoing COVID-19 situation, gynecologists are managing antenatal care during pregnancy through online video sessions to limit exposure to the outside world. However, asymptomatic patients from the U.S. were able to continue with their initial treatment plan. Most oocyte donation treatments and all embryo transferences from patients follow the recommended “freeze-all” strategy and later embryo transfer are being performed under controlled conditions.
Moreover, egg donation treatments are canceled, and frozen embryos are preserved for later use. Furthermore, many ongoing pregnancies have been struggling, owing to the disruption caused by COVID-19 pandemic. The patient treatment schedule has been changed, owing to which the patients have to face huge emotional dissatisfaction and uncertainty.
The ongoing pregnancies by IVF are also struggling for necessary scans and medicines. Thus, factors mentioned above impact the fertility services market and in turn limit the adoption of fertility services in the developed markets.
By Procedure
IVF with ICSI segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Fertility Services Market Segmentation
The Asia-Pacific fertility services market is classified into procedure, service, end user, and country. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, it is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. On the basis of country, the market is analyzed across Japan, India, China, Australia, South Korea, Thailand, Malaysia, Singapore, New Zealand, Philippines, Indonesia, and the rest of Asia-Pacific.
Segment review
By fertility services market analysis, the IVF with ICSI segment accounted for half of the market share in the fertility services market in 2020. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. Moreover, the rapid increase in the infertility rate is one of the major factors that drive the growth of the fertility services market.
By Service
Fresh Non-donor segment is projected as the most promising segment.
By procedure, the IVF with ICSI segment accounted for the largest market share in 2020. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires a smaller number of sperms that are penetrated into the egg with the help of injection technique.
Asia-Pacific presents lucrative opportunities for key players operating in the fertility services market, owing to the increase in accessibility and availability of healthcare facilities and a rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development. Moreover, the fertility services in countries such as India are cheaper as compared to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth in this region. The growth of the fertility services market is supplemented by a surge in the adoption of fertility procedures and a rise in fertility tourism. China dominated the Asia-Pacific fertility services market in 2020 and is expected to register the highest CAGR during the forecast period. This is attributed to increase in awareness and acceptance within the country for adopting fertility services.
By End User
Fertility Clinics segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
The key players operating in the Asia-Pacific fertility services market include Apollo Hospitals Enterprise Ltd, CooperSurgical, Inc., City Fertility, ESCO Life Sciences Group, Fertility Associates Limited, Genea Limited, Medicover Group, Monash IVF Group Limited, Thermo Fisher Scientific Inc., and Virtus Health.
By Country
China was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the fertility services market, and the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing Asia-Pacific fertility services market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the Asia-Pacific fertility services market.
Key Market Segments
By Procedure
- IVF with ICSI
- IUI
- IVF without ICSI
- Surrogacy
- Others
By Service
- Fresh Non-donor
- Frozen Non-donor
- Egg & Embryo Banking
- Fresh Donor
- Frozen Donor
By End User
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
By Country
- Japan
- India
- China
- Australia
- South Korea
- Thailand
- Malaysia
- Singapore
- New Zealand
- Philippines
- Indonesia
- Rest of Asia-Pacific
List of key players profiled in the report
- Apollo Hospitals Enterprise Ltd
- CooperSurgical, Inc.
- City Fertility
- ESCO Life Sciences Group
- Fertility Associates Limited
- Genea Limited
- Medicover Group
- Monash IVF Group Limited
- Thermo Fisher Scientific Inc.
- Virtus Health
Asia-Pacific Fertility Services Market, by Procedure Report Highlights
| Aspects | Details |
 By Procedure |
|
 By Service |
|
 By End User |
|
 By Country |
|
 Key Market Players | GENEA LIMITED, ESCO LIFE SCIENCES GROUP, THERMO FISHER SCIENTIFIC INC., COOPERSURGICAL, INC., MONASH IVF GROUP LIMITED, FERTILITY ASSOCIATES LIMITED, APOLLO HOSPITALS ENTERPRISE LTD., CITY FERTILITY, MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK), VIRTUS HEALTH |
Analyst Review
This section provides the opinions of the top-level CXOs in the Asia-Pacific fertility services industry. According to the CXOs, fertility services include assisted reproductive technology procedures undertaken by couples who cannot conceive naturally.
These services are availed to treat infertility. These services often include techniques like artificial insemination, in vitro fertilization (IVF), surrogacy, and more. Out of all these techniques, IVF is the one used and chosen most widely. In IVF the sperm is combined with the egg in vitro. The process involves the stimulation and monitoring of the woman's ovulation process, removing the eggs (ova) from the ovaries, and letting the sperm fertilize them in a laboratory's culture medium. IVF is mostly prescribed to women with blocked or missing oviducts (fallopian tubes). Some other causes that cause female infertility such as endometriosis, fibroids, polycystic ovary syndrome (PCOS), and cervical problems might also require intervention with IVF.
According to the CXOs, the fertility services market is anticipated to witness considerable growth in the future, owing to the emerging trend of delayed first-time pregnancy among women, rise in prevalence of infertility in both males and females, technological advancements in assisted reproductive technology (ART) procedures, and increased incidence of sperms and eggs donations.
Furthermore, the increase in the prevalence of IVF procedures and a rise in awareness regarding surrogacy, egg freezing, and egg banks are expected to fuel the growth of the market. However, insufficient reimbursement policies for couples opting for fertility procedures and stringent regulations in some countries against fertility procedures for single patients and members from the LGBT community are some of the factors that can impede market growth during the forecast period.
However, emerging markets such as India are offering fertility procedures for single parents and same-sex couples which might offer lucrative growth opportunities for market expansion in the Asia-Pacific region.
The total market value of fertility services market was $4,529.06 million in 2020.
The forcast period for fertility services market is 2021 to 2030
The market value of fertility services market in 2030 will be $20,492.95 million.
The base year is 2020 for the fertility services market
Top companies such as Apollo Hospitals Enterprise Ltd., CooperSurgical, Inc., Fertility Associates Limited, Genea Limited and others held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
In procedure segment IVF with ICSI is the most influencing segment. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. In addition, rise in awareness regarding IVF with ICSI also have a positive effect on the market.
The major factor that fuels the growth of the Asia-Pacific fertility services market includes continuous decline in fertility rates, trend of delayed pregnancy in women, and technological advancements with respect to fertility treatment is expected growth of the market. On the contrary, developing economies and untapped markets are expected to provide lucrative opportunities for the market growth in the future.
Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to the fertility services in countries such as India are cheaper as compare to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth of fertility services in this region, development in healthcare infrastructure, and rise in number of hospitals & research centers equipped with advanced medical facilities.
Infertility is a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse
IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others.
Loading Table Of Content...
